Micheli F, Fernandez Pardal M M, Gatto E, Paradiso G
Department of Neurology, Hospital de Clínicas José de San Martín, University of Buenos Aires, Argentina.
Clin Neuropharmacol. 1988 Jun;11(3):241-9. doi: 10.1097/00002826-198806000-00006.
Meige's disease is a distressing complaint, the treatment of which often poses a challenge to the neurologist. The patient described here had blepharospasm-oromandibular dystonia, which responded transiently to oral lisuride. On three occasions, drug holidays successfully restored efficacy but thereafter further trials proved fruitless. Continuous subcutaneous lisuride administration in 0.35 mg doses per day, by means of a portable infusion pump, led to sustained improvement for 7 months. No major side effects were observed. Our findings suggest that this treatment deserves further trials.
梅杰氏病是一种令人痛苦的病症,其治疗常常给神经科医生带来挑战。此处描述的患者患有眼睑痉挛 - 口下颌肌张力障碍,口服利苏立得后有短暂反应。有三次,停药期成功恢复了疗效,但此后进一步试验均无果。通过便携式输液泵每天以0.35毫克剂量持续皮下注射利苏立得,带来了长达7个月的持续改善。未观察到重大副作用。我们的研究结果表明这种治疗值得进一步试验。